©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Table 6 Diagnostic performance of the indices for controlled attenuation parameter
| Indices | AUC | P value | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
| FIB-4 | 0.516 | 0.769 | 40.54 | 72.09 | 71.43 | 41.33 |
| APRI | 0.566 | 0.236 | 50.08 | 32.56 | 67.42 | 50 |
| NPAR | 0.467 | 0.553 | 16.22 | 97.67 | 92.31 | 40.38 |
| NLR | 0.474 | 0.57 | 45.34 | 92.77 | 91.58 | 40.38 |
| PLR | 0.54 | 0.388 | 58.14 | 54.05 | 59.52 | 52.63 |
- Citation: Joseph A, Mathew S, Nair HR. Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 113475
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113475.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113475